Recent advances in cell membrane camouflaged nanotherapeutics for the treatment of bacterial infection
- PMID: 38697197
- DOI: 10.1088/1748-605X/ad46d4
Recent advances in cell membrane camouflaged nanotherapeutics for the treatment of bacterial infection
Abstract
Infectious diseases caused by bacterial infections are common in clinical practice. Cell membrane coating nanotechnology represents a pioneering approach for the delivery of therapeutic agents without being cleared by the immune system in the meantime. And the mechanism of infection treatment should be divided into two parts: suppression of pathogenic bacteria and suppression of excessive immune response. The membrane-coated nanoparticles exert anti-bacterial function by neutralizing exotoxins and endotoxins, and some other bacterial proteins. Inflammation, the second procedure of bacterial infection, can also be suppressed through targeting the inflamed site, neutralization of toxins, and the suppression of pro-inflammatory cytokines. And platelet membrane can affect the complement process to suppress inflammation. Membrane-coated nanoparticles treat bacterial infections through the combined action of membranes and nanoparticles, and diagnose by imaging, forming a theranostic system. Several strategies have been discovered to enhance the anti-bacterial/anti-inflammatory capability, such as synthesizing the material through electroporation, pretreating with the corresponding pathogen, membrane hybridization, or incorporating with genetic modification, lipid insertion, and click chemistry. Here we aim to provide a comprehensive overview of the current knowledge regarding the application of membrane-coated nanoparticles in preventing bacterial infections as well as addressing existing uncertainties and misconceptions.
Keywords: bacteria; cell membrane; inflammation; ligands; nanoparticles; polylactic acid-glycolic acid copolymer.
© 2024 IOP Publishing Ltd.
Similar articles
-
Cell membrane-coated nanoparticles for the treatment of bacterial infection.Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2022 Sep;14(5):e1825. doi: 10.1002/wnan.1825. Epub 2022 Jun 20. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2022. PMID: 35725897 Review.
-
The Prospect of Biomimetic Immune Cell Membrane-Coated Nanomedicines for Treatment of Serious Bacterial Infections and Sepsis.J Pharmacol Exp Ther. 2024 May 21;389(3):289-300. doi: 10.1124/jpet.123.002095. J Pharmacol Exp Ther. 2024. PMID: 38580449 Free PMC article. Review.
-
Nanoparticle formulations for therapeutic delivery, pathogen imaging and theranostic applications in bacterial infections.Theranostics. 2023 Mar 5;13(5):1545-1570. doi: 10.7150/thno.82790. eCollection 2023. Theranostics. 2023. PMID: 37056563 Free PMC article. Review.
-
An electroporation strategy to synthesize the membrane-coated nanoparticles for enhanced anti-inflammation therapy in bone infection.Theranostics. 2021 Jan 1;11(5):2349-2363. doi: 10.7150/thno.48407. eCollection 2021. Theranostics. 2021. PMID: 33500729 Free PMC article.
-
Nanotechnology in inflammation: cutting-edge advances in diagnostics, therapeutics and theranostics.Theranostics. 2024 Apr 8;14(6):2490-2525. doi: 10.7150/thno.91394. eCollection 2024. Theranostics. 2024. PMID: 38646646 Free PMC article. Review.
Cited by
-
Armored polymyxin B: a nanosystem for combating multidrug-resistant Gram-negative bacilli.RSC Adv. 2024 Dec 17;14(53):39700-39707. doi: 10.1039/d4ra07577c. eCollection 2024 Dec 10. RSC Adv. 2024. PMID: 39691227 Free PMC article.
-
Macrophage membrane coated nanoscale coordination polymers promote graft survival in allogeneic transplantation.J Nanobiotechnology. 2025 Apr 7;23(1):284. doi: 10.1186/s12951-025-03226-z. J Nanobiotechnology. 2025. PMID: 40197267 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical